View Cart (0 items)

Clorox release

April 08, 2009
/ Print / Reprints /
| Share More
/ Text Size+
Oakland, CA — Clorox Commercial Solutions® Ultra Clorox® Germicidal Bleach is the first and only product to obtain federal EPA registration for killing Clostridium difficle (C. diff) spores on hard, non-porous surfaces when used as directed.
C. diff causes a wide variety of symptoms, from diarrhea to more serious life threatening intestinal disease. A study by the Association for Professionals in Infection Control (APIC) found that C. diff infection rates are 6.5 to 20 times higher than previous estimates. The study concluded that C. diff infections cost American healthcare institutions $17.6 to $51.5 million each day.
C. diff may occur intwo forms – vegetative and spore. Although the vegetative cells die rapidly on surfaces and are relatively easy to kill with disinfecting products, C. diff spores can persist in the environment for many months and are highly resistant to many disinfecting formulations.
After completing a rigorous review process, Clorox Commercial Solutions Ultra Clorox Germicidal Bleach is the first and only EPA registered product shown to be effective against spores of C. diff. This disinfectant is registered for use in all 50 states.
For more information on C. diff, Clorox Commercial Solutions Ultra Clorox Germicidal Bleach or other Clorox Commercial Solutions branded products, visit www.cloroxprofessional.com/cdiff or e-mail Healthcare@clorox.com.
You must login or register in order to post a comment.